FDA — authorised 15 December 1986
- Application: NDA019500
- Marketing authorisation holder: NOVARTIS
- Local brand name: LAMPRENE
- Indication: CAPSULE — ORAL
- Status: approved
🇺🇸 Clofazimine Oral Product in United States
FDA authorised Clofazimine Oral Product on 15 December 1986
Marketing authorisation
Other Infectious Disease approved in United States
Frequently asked questions
Is Clofazimine Oral Product approved in United States?
Yes. FDA authorised it on 15 December 1986.
Who is the marketing authorisation holder for Clofazimine Oral Product in United States?
NOVARTIS holds the US marketing authorisation.